Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15790 articles
Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancer
YZ-836P promoted ubiquitination and degradation of PRMT5.
»
11/30/24
Prognostic effect of immunohistochemically determined molecular subtypes in gastric cancer
Epstein–Barr virus (EBV)-positive subtype exhibited worst prognosis.
»
12/02/24
Immune alterations and overexpression of CTCF in endometrial carcinoma: insights from molecular subtyping
GSPAdb online database identified differential expression pathways.
»
12/02/24
NF-kappa B associated markers of prognosis in early and metastatic triple negative breast cancer
NF-kappa B signaling driven by lymphotoxin beta expression associated with tumor regression.
»
12/02/24
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment
Dual FGFR/VEGFR inhibitors decrease acral-analogous melanocyte proliferation.
»
12/03/24
A retrospective study of provisional outcomes of intracorporeal esophagojejunostomy versus extracorporeal anastomosis during laparoscopic total gastrectomy for gastric cancer. a single -center
Anastomosis bleeding only occurred in EEJ.
»
12/03/24
Short-term and long-term oncological outcomes of chemoradiotherapy for rectal cancer patients with or without oxaliplatin: a propensity score-matched retrospective analysis
CAPEOX significantly increased likelihood of achieving pathologic complete response.
»
12/03/24
Social vulnerability is associated with advanced breast cancer presentation and all-cause mortality: a retrospective cohort study
Each decile increase in SVI associated with 6% increase in all-cause mortality risk.
»
12/03/24
Real-world evidence of Trastuzumab Deruxtecan (T-DXd) Efficacy in HER2-expressing gynecological malignancies
T-DXd showed activity in cohort of heavily pre-treated patients with HER2-expressing malignancies.
»
12/05/24
The epidemiological trends and predictions of esophageal squamous cell carcinoma and gastroesophageal junction carcinoma: an Australian population-based study
10-year survival rate for GEJC and ESCC low.
»
12/05/24
< Prev
Next >